Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 525 of 2529 entries
View as:

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Phase: N/A Priority: Normal
NCT ID: NCT05156281 Org: User:
Start: 12/13/21 End: 10/30/30 Due: 10/30/31

Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT02038036 Org: User:
Start: 03/25/14 End: 04/07/20 Due: 04/07/21

Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT05857748 Org: User:
Start: 07/31/23 End: 12/30/24 Due: 12/30/25

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

Phase: N/A Priority: Normal
NCT ID: NCT04662944 Org: User:
Start: 02/23/21 End: 06/28/23 Due: 06/28/24

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT04582409 Org: User:
Start: 11/30/20 End: 07/11/22 Due: 07/11/23

An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06617793 Org: User:
Start: 02/24/25 End: 10/01/30 Due: 10/01/31

Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans

Phase: N/A Priority: Normal
NCT ID: NCT00739596 Org: User:
Start: 07/31/08 End: 03/31/09 Due: 03/31/10

Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00219284 Org: User:
Start: 01/31/05 End: 07/31/08 Due: 07/31/09

A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01231594 Org: User:
Start: 11/05/10 End: 04/09/18 Due: 04/09/19

A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01232296 Org: User:
Start: 07/31/11 End: 04/30/14 Due: 04/30/15

A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)

Phase: N/A Priority: Normal
NCT ID: NCT01708174 Org: User:
Start: 05/06/13 End: 10/05/16 Due: 10/05/17

Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT01623596 Org: User:
Start: 06/08/12 End: 07/13/15 Due: 07/13/16

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT06846281 Org: User:
Start: 06/16/25 End: 03/10/32 Due: 03/10/33

Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03387163 Org: User:
Start: 02/09/18 End: 06/21/19 Due: 06/21/20

Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase

Phase: N/A Priority: Normal
NCT ID: NCT00451035 Org: User:
Start: 02/19/07 End: 09/30/08 Due: 09/30/09

A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT06923124 Org: User:
Start: 03/30/23 End: 05/28/24 Due: 05/28/25

A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT00420524 Org: User:
Start: 01/31/06 End: - Due: -

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT00600938 Org: User:
Start: 11/30/07 End: 03/31/13 Due: 03/31/14

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01852292 Org: User:
Start: 10/01/13 End: 03/30/17 Due: 03/30/18

Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02404350 Org: User:
Start: 08/31/15 End: 01/24/19 Due: 01/24/20

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

Phase: N/A Priority: Normal
NCT ID: NCT05082415 Org: User:
Start: 06/03/20 End: 12/15/20 Due: 12/15/21

Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03628053 Org: User:
Start: 06/05/20 End: 01/07/26 Due: 01/07/27

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Phase: N/A Priority: Normal
NCT ID: NCT01232595 Org: User:
Start: 10/31/10 End: 07/31/13 Due: 07/31/14

Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03626545 Org: User:
Start: 01/23/19 End: 12/20/21 Due: 12/20/22

Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)

Phase: N/A Priority: Normal
NCT ID: NCT00774020 Org: User:
Start: 10/30/08 End: 01/14/11 Due: 01/14/12